Children with sickle cell anemia who took 20 milligrams of zinc daily experienced nearly 40 percent fewer infections, according to research reported by Newswise. The finding points to a low-cost, accessible intervention for a condition that leaves patients highly vulnerable to serious illness.
Sickle cell anemia is an inherited blood disorder that causes red blood cells to form an abnormal crescent shape. Those misshapen cells can block blood flow, cause severe pain, and damage organs. People with the disease also have weakened immune function, making infections a leading cause of illness and death, particularly in children.
The study tested a daily 20-milligram dose of zinc as a supplement in pediatric patients with the disease. Researchers tracked infection rates and found the reduction was substantial enough to draw attention as a potential standard addition to sickle cell care.
Zinc is a mineral involved in immune system function. It is relatively inexpensive and widely available, which makes it a practical option for patients in both high-income and low-income settings. The significance of the finding extends to parts of the world where sickle cell anemia is most common and where access to complex medical treatments is limited.
The research was highlighted by Newswise as a meaningful step toward reducing the infection burden that children with sickle cell anemia face throughout their lives. Infections in these patients can escalate quickly and require hospitalization, so a preventive measure with a nearly 40 percent reduction rate carries real clinical weight.
Further research will be needed to determine how zinc supplementation fits into existing treatment protocols and whether the findings hold across different patient populations and age groups.
